Weaver Consulting Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Sell
5,049
-61
-1% -$14.2K 0.29% 75
2025
Q4
$1.06M Sell
5,110
-29
-0.6% -$5.74K 0.26% 80
2025
Q3
$953K Sell
5,139
-49
-0.9% -$8.39K 0.24% 84
2025
Q2
$792K Sell
5,188
-56
-1% -$8.61K 0.22% 87
2025
Q1
$870K Sell
5,244
-166
-3% -$26K 0.26% 74
2024
Q4
$782K Sell
5,410
-149
-3% -$23.1K 0.24% 79
2024
Q3
$901K Buy
5,559
+4
+0.1% +$637 0.29% 73
2024
Q2
$812K Buy
5,555
+28
+0.5% +$4.16K 0.28% 75
2024
Q1
$874K Sell
5,527
-16
-0.3% -$2.55K 0.32% 68
2023
Q4
$869K Buy
5,543
+39
+0.7% +$5.98K 0.35% 57
2023
Q3
$857K Sell
5,504
-43
-0.8% -$7.09K 0.39% 56
2023
Q2
$918K Buy
5,547
+9
+0.2% +$1.45K 0.41% 53
2023
Q1
$858K Buy
5,538
+446
+9% +$72K 0.39% 53
2022
Q4
$900K Sell
5,092
-539
-10% -$93.1K 0.46% 46
2022
Q3
$920K Sell
5,631
-222
-4% -$37.6K 0.53% 40
2022
Q2
$1.04M Buy
5,853
+105
+2% +$18.7K 0.58% 37
2022
Q1
$1.02M Sell
5,748
-206
-3% -$35.1K 0.49% 38
2021
Q4
$1.02M Sell
5,954
-61
-1% -$9.99K 0.49% 40
2021
Q3
$971K Sell
6,015
-492
-8% -$83.9K 0.53% 38
2021
Q2
$1.07M Sell
6,507
-311
-5% -$51.5K 0.6% 36
2021
Q1
$1.12M Buy
6,818
+583
+9% +$94.3K 0.69% 35
2020
Q4
$981K Buy
6,235
+449
+8% +$66.3K 0.61% 36
2020
Q3
$861K Sell
5,786
-17
-0.3% -$2.52K 0.5% 40
2020
Q2
$816K Buy
5,803
+430
+8% +$62.7K 0.47% 44
2020
Q1
$705K Sell
5,373
-191
-3% -$27.1K 0.46% 46
2019
Q4
$720K Buy
5,564
+232
+4% +$31.5K 0.39% 48
2019
Q3
$704K Buy
5,332
+2
+0% +$263 0.37% 47
2019
Q2
$742K Hold
5,330
0.4% 45
2019
Q1
$741K Buy
+5,330
New +$714K 0.21% 82

Other funds holding JNJ

Weaver Consulting Group's JNJ Position: Q1 2026 in Review

Weaver Consulting Group reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $14.2K and leaving 5,049 shares worth $1.23M. The position accounts for 0.29% of the portfolio, ranked #75.

Weaver Consulting Group first reported a position in JNJ in Q1 2019 and has held it in 29 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Weaver Consulting Group held 5,049 shares of Johnson & Johnson worth $1.23M as of Q1 2026.
  • Weaver Consulting Group sold 61 Johnson & Johnson shares in Q1 2026, an estimated $14.2K.
  • Johnson & Johnson made up 0.29% of Weaver Consulting Group's portfolio in Q1 2026, its #75 holding.
  • Weaver Consulting Group first reported a position in Johnson & Johnson in Q1 2019 and has held it in 29 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Weaver Consulting Group's 13F filing for Q1 2026, filed 15 May 2026.